Enhanced gene transfer to rabbit jugular veins by an adenovirus containing a cyclic RGD motif in the HI loop of the fiber knob

Journal of Vascular Research

Volumn 38, Issue 4, 2001, Pages 315-323

  Hay, Carl M ^a   De Leon, Hector ^a   Jafari, Jonathon D ^a   Jakubczak, John L ^a   Mech, Christine A ^a   Hallenbeck, Paul L ^a   Powell, Sharon K ^a   Liau, Gene ^a   Stevenson, Susan C ^a  

^a NOVARTIS PHARMA AG   (Switzerland)

Author keywords

Adenovirus; Gene therapy; Jugular veins; Targeted adenoviral vectors

Indexed keywords

ARGINYLGLYCYLASPARTIC ACID; BETA GALACTOSIDASE; INTEGRIN; VIRUS VECTOR;

ADENOVIRUS; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; GENE EXPRESSION; GENE INSERTION; GENE THERAPY; GENE TRANSFER; HUMAN; HUMAN CELL; JUGULAR VEIN; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN MOTIF; RAT; REPORTER GENE; STENOSIS; TRANSGENE; VASCULAR SMOOTH MUSCLE;

ADENOVIRIDAE; AMINO ACID SEQUENCE; ANIMALS; ANTIGENS, CD; CAPSID; CAPSID PROTEINS; ENDOTHELIUM, VASCULAR; ESCHERICHIA COLI; GENE EXPRESSION; GENE TRANSFER, HORIZONTAL; GENETIC VECTORS; HISTOCYTOCHEMISTRY; INTEGRIN ALPHAV; JUGULAR VEINS; MICE; MICE, INBRED C57BL; MUSCLE, SMOOTH, VASCULAR; ORGAN CULTURE TECHNIQUES; RABBITS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, IMMUNOLOGIC; RECEPTORS, PEPTIDE; RECOMBINANT FUSION PROTEINS; SPECIES SPECIFICITY; TRANSFECTION;

EID: 0034912541     PISSN: 10181172     EISSN: None     Source Type: Journal    
DOI: 10.1159/000051062     Document Type: Article

References (41)

1. Influence of the internal-mammary-artery graft on 10-year survival and other cardiac events
2. Coronary bypass surgery with internal-thoracic-artery grafts - Effects on survival over a 15-year period
3. Different interactions of platelets with arterial and venous coronary bypass vessels
4. The future of saphenous vein as a coronary artery bypass conduit
5. Morphologic findings in saphenous veins used as coronary arterial bypass conduits for longer than 1 year: Necropsy analysis of 53 patients, 123 saphenous veins, and 1,865 five-millimeter segments of veins
6. The role of gene therapy for intimal hyperplasia of bypass grafts
7. Targets for gene therapy of vein grafts
8. Integrins alpha v beta 3 and alpha v beta 5 promote adenovirus internalization but not virus attachment
9. Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5
10. Human adenovirus serotypes 3 and 5 bind to two different cellular receptors via the fiber head domain
11. Adenovirus type 5 fiber knob binds to MHC class I alpha2 domain at the surface of human epithelial and B lymphoblastoid cells
12. Mutations that alter an Arg-Gly-Asp (RGD) sequence in the adenovirus type 2 penton base protein abolish its cell-rounding activity and delay virus reproduction in flat cells
13. Role of alpha(v) integrins in adenovirus cell entry and gene delivery
14. Selective targeting of human cells by a chimeric adenovirus vector containing a modified fiber protein
15. Alpha v integrins as receptors for tumor targeting by circulating ligands
16. Gene splicing by overlap extension: Tailor-made genes using the polymerase chain reaction
17. Elimination of both E1 and E2 from adenovirus vectors further improves prospects for in vivo human gene therapy
18. Crystal structure of the receptor-binding domain of adenovirus type 5 fiber protein at 1.7 A resolution
19. Efficient generation of recombinant adenovirus vectors by homologous recombination in Escherichia coli
20. Evaluation of the efficacy and safety of in vitro, adenovirus-mediated transfer of the human cystic fibrosis transmembrane conductance regulator cDNA
21. Adenovirus-mediated gene transfer of the human TIMP-1 gene inhibits smooth muscle cell migration and neointimal formation in human saphenous vein
22. Prevention of vein graft failure: Potential applications for gene therapy
23. Role of alveolar macrophages in rapid elimination of adenovirus vectors administered to the epithelial surface of the respiratory tract
24. Clearance of adenovirus-infected hepatocytes by MHC class I-restricted CD4+ CTLs in vivo
25. Ex-vivo gene therapy of human vascular bypass grafts with E2F decoy: The PREVENT single-centre, randomised, controlled trial
26. Efficient adenoviral gene transfer to early venous bypass grafts: Comparison with native vessels
27. Targeted adenovirus gene transfer to endothelial and smooth muscle cells by using bispecific antibodies
28. Targeted gene delivery by tropism-modified adenoviral vectors
29. Targeted gene delivery to Kaposi's sarcoma cells via the fibroblast growth factor receptor
30. Basic fibroblast growth factor enhancement of adenovirus-mediated delivery of the herpes simplex virus thymidine kinase gene results in augmented therapeutic benefit in a murine model of ovarian cancer
31. Increased in vitro and in vivo gene transfer by adenovirus vectors containing chimeric fiber proteins
32. Efficient adenoviral gene transfer to kidney cortical vasculature utilizing a fiber modified vector
33. An adenovirus vector with genetically modified fibers demonstrates expanded tropism via utilization of a coxsackievirus and adenovirus receptor-independent cell entry mechanism
34. Selective gene delivery to head and neck cancer cells via an integrin targeted adenoviral vector
35. Effects of cardiopulmonary bypass on leukocyte and endothelial adhesion molecules
36. Time course of beta 2-integrin CD11b/CD18 (Mac-1, alpha M beta 2) upregulation on neutrophils and monocytes after coronary artery bypass grafting. CD11b upregulation after CABG surgery
37. Neutrophils sense flow-generated stress and direct their migration through alphaV-beta3-integrin
38. Mechanical stretching of human saphenous vein grafts induces expression and activation of matrix-degrading enzymes associated with vascular tissue injury and repair
39. Inhibition of neointima formation by a nonpeptide alpha(v)beta(3) integrin receptor antagonist in a rabbit cuff model
40. Targeting endothelium for gene therapy via receptors up-regulated during angiogenesis and inflammation
41. Optimization of ex vivo inducible nitric oxide synthase gene transfer to vein grafts